Once the Park Medi World IPO allotment is finalised, investors who applied for the issue can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue
Applicants can check their Nephrocare Health IPO allotment status on the official websites of NSE and BSE, or the registrar Kfin Technologies
Corona Remedies IPO received an overwhelming investor interest, achieving an overall oversubscription of 137 times, driven largely by strong participation from QIBs
The ₹10,602.65-crore IPO is a pure Offer for Sale (OFS), with Prudential Corporation Holdings offloading up to 49 million (48,972,994) equity shares, as detailed in the Red Herring Prospectus (RHP)
ICICI Prudential AMC IPO: Analysts at Canara Bank Securities and Anand Rathi have recommended subscribing to the issue from a long-term perspective
Applicants can check their Wakefit Innovations IPO allotment status on the official websites of NSE and BSE, or the registrar Kfin Technologies
Once the allotment is finalised, investors who applied for Corona Remedies IPO can check their status on the official websites of BSE, NSE, or Bigshare Services, the registrar for the issue
Corona Remedies IPO received bids for 229.5 million shares against 4.57 million shares on offer as of 02:00 PM on December 10
Meesho Share Price Today: Post-listing, Meesho shares continue to trade higher on the bourses on Wednesday
The listing closely mirrored activity in the grey market, where the company's shares were quoted around ₹154 each, indicating a premium of ₹43, or 38.74 per cent over the issue price
Park Medi World raised ₹276 crore from 23 institutional investors via an anchor book on December 5
Here are the key details of the Nephrocare Health Services IPO that every investor should be aware of before placing bids for the public offering
Nephrocare Health IPO comprises a fresh issue of 7.7 million, amounting to ₹353.4 crore and an offer for sale (OFS) of 11.3 million equity shares amounting to ₹517.64 crore
The three-day subscription window to bid for the Park Medi World IPO will close on Friday, December 12, 2025
Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent
Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer
Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares
The unlisted shares of Park Medi World were trading at ₹193 in the grey market, commanding a premium of ₹33 or 20 per cent from the upper end price of ₹162
Corona Remedies IPO: Check price band, lot size GMP, subscription status, reviews, and other key details here
Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue